Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative

Stem Cells

Volumn 30, Issue 10, 2012, Pages 2234-2247

  Kako, Eisuke ^a   Kaneko, Naoko ^a   Aoyama, Mineyoshi ^a   Hida, Hideki ^a   Takebayashi, Hirohide ^b   Ikenaka, Kazuhiro ^b   Asai, Kiyofumi ^a   Togari, Hajime ^a   Sobue, Kazuya ^a   Sawamoto, Kazunobu ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Differentiation; Erythropoietin; Hypoxia; Neural stem cell; Oligodendrocytes; Tissue regeneration

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN INJURY; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; HEMATOPOIESIS; MOUSE; NONHUMAN; OLIGODENDROGENESIS; OLIGODENDROGLIA; SUBVENTRICULAR ZONE; WHITE MATTER INJURY;

ANIMALS; ANIMALS, NEWBORN; ASIALOGLYCOPROTEINS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL PROLIFERATION; CEREBRAL VENTRICLES; ERYTHROPOIETIN; GENE EXPRESSION; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; STEM CELLS;

ANIMALIA; MUS;

EID: 84866646924     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1202     Document Type: Article

References (98)

1. Moster D, Wilcox AJ, Vollset SE et al. Cerebral palsy among term and postterm births. J Am Med Assoc 2010;304:976-982.
2. Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy. J Am Med Assoc 2006;296:1602-1608.
3. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns - Dry numbers, wet lab, and causal inferences. Early Hum Dev 2004;79:1-15.
4. Fukuda S, Kato T, Kakita H et al. Hemodynamics of the cerebral arteries of infants with periventricular leukomalacia. Pediatrics 2006;117:1-8.
5. Lechpammer M, Manning SM, Samonte F et al. Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathol Appl Neurobiol 2008;34:379-393.
6. Gerstner B, Lee J, DeSilva TM et al. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res 2009;87:2078-2086.
7. Manning SM, Talos DM, Zhou C et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 2008;28:6670-6678.
8. Adhami F, Yu D, Yin W et al. Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am J Pathol 2008;172:1704-1716.
9. Franklin RJM, Ffrench-Constant C. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 2008;9:839-855.
10. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders - Time for clinical translation? J Clin Invest 2010;120:29-40.
11. Okano H, Sawamoto K. Neural stem cells: Involvement in adult neurogenesis and CNS repair. Philos Trans R Soc Lond B Biol Sci 2008;363:2111-2122.
12. Ming GL, Song H. Adult neurogenesis in the mammalian brain: Significant answers and significant questions. Neuron 2011;70:687-702.
13. Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 2009;32:149-184.
14. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell 2008;132:645-660.
15. Kaneko N, Sawamoto K. Adult neurogenesis and its alteration under pathological conditions. Neurosci Res 2009;63:155-164.
16. Luskin MB. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 1993;11:173-189.
17. Sawamoto K, Wichterle H, Gonzalez-Perez O et al. New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 2006;311:629-632.
18. Kaneko N, Marin O, Koike M et al. New neurons clear the path of astrocytic processes for their rapid migration in the adult brain. Neuron 2010;67:213-223.
19. Yamashita T, Ninomiya M, Hernandez Acosta P et al. Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci 2006;26:6627-6636.
20. Ninomiya M, Yamashita T, Araki N et al. Enhanced neurogenesis in the ischemic striatum following EGF-induced expansion of transit-amplifying cells in the subventricular zone. Neurosci Lett 2006;403:63-67.
21. Kojima T, Hirota Y, Ema M et al. Subventricular zone-derived neural progenitor cells migrate along a blood vessel scaffold toward the post-stroke striatum. Stem Cells 2010;28:545-554.
22. Levison SW, Goldman JE. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 1993;10:201-212.
23. Picard-Riera N, Decker L, Delarasse C et al. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci USA 2002;99:13211-13216.
24. Menn B, Garcia-Verdugo JM, Yaschine C et al. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 2006;26:7907-7918.
25. Nait-Oumesmar B, Picard-Riera N, Kerninon C et al. Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors. Proc Natl Acad Sci USA 2007;104:4694-4699.
26. Nait-Oumesmar B, Decker L, Lachapelle F et al. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci 1999;11:4357-4366.
27. Azim K, Butt AM. GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 2011;59:540-553.
28. Fancy SPJ, Baranzini SE, Zhao C et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 2009;23:1571-1585.
29. Aguirre A, Dupree JL, Mangin JM et al. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci 2007;10:990-1002.
30. Patel JR, McCandless EE, Dorsey D et al. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 2010;107:11062-11067.
31. Huang JK, Jarjour AA, Nait Oumesmar B et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011;14:45-53.
32. Mi S, Lee X, Hu Y et al. Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nat Med 2011;17:816-821.
33. Fancy SP, Harrington EP, Yuen TJ et al. Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 2011;14:1009-1016.
34. Sakanaka M, Wen TC, Matsuda S et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998;95:4635-4640.
35. Wang L, Zhang Z, Wang Y et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004;35:1732-1737.
36. Gonzalez FF, McQuillen P, Mu D et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 2007;29:321-330.
37. Liu W, Shen Y, Plane JM et al. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Exp Neurol 2011;230:227-239.
38. Iwai M, Cao G, Yin W et al. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 2007;38:2795-2803.
39. Iwai M, Stetler RA, Xing J et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke 2010;41:1032-1037.
40. Sugawa M, Sakurai Y, Ishikawa-Ieda Y et al. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 2002;44:391-403.
41. Stohlawetz PJ, Dzirlo L, Hergovich N et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 2000;95:2983-2989.
42. Coleman TR, Westenfelder C, Togel FE et al. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci USA 2006;103:5965-5970.
43. Dimou L, Simon C, Kirchhoff F et al. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci 2008;28:10434-10442.
44. Erbayraktar S, Grasso G, Sfacteria A et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA 2003;100:6741-6746.
45. Takebayashi H, Nabeshima Y, Yoshida S et al. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol 2002;12:1157-1163.
46. Srinivas S, Watanabe T, Lin CS et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001;1:4.
47. Rice JE, 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131-141.
48. Mizuno K, Hida H, Masuda T et al. Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: A rat model. Neonatology 2008;94:255-266.
49. Kato S, Aoyama M, Kakita H et al. Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury. J Neurosci Res 2011;89:1566-1574.
50. Tatsumi K, Takebayashi H, Manabe T et al. Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytes. J Neurosci Res 2008;86:3494-3502.
51. Islam MS, Tatsumi K, Okuda H et al. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochem Int 2009;54:192-198.
52. Arai K, Lo EH. An oligovascular niche: Cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J Neurosci 2009;29:4351-4355.
53. Hernandez TD, Schallert T. Seizures and recovery from experimental brain damage. Exp Neurol 1988;102:318-324.
54. Ness JK, Romanko MJ, Rothstein RP et al. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 2001;23:203-208.
55. Seri B, Herrera DG, Gritti A et al. Composition and organization of the SCZ: A large germinal layer containing neural stem cells in the adult mammalian brain. Cereb Cortex 2006;16:i103-i111.
56. Parent JM, von dem Bussche N, Lowenstein DH. Prolonged seizures recruit caudal subventricular zone glial progenitors into the injured hippocampus. Hippocampus 2006;16:321-328.
57. Petreanu L, Alvarez-Buylla A. Maturation and death of adult-born olfactory bulb granule neurons: Role of olfaction. J Neurosci 2002;22:6106-6113.
58. Doetsch F, Caille I, Lim DA et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999;97:703-716.
59. Tripathi RB, Rivers LE, Young KM et al. NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neurosci 2011;30:16383-16390.
60. Rabie T, Marti HH. Brain protection by erythropoietin: A manifold task. Physiology (Bethesda) 2008;23:263-274.
61. Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 2004;207:3233-3242.
62. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-jB signalling cascades. Nature 2001;412:641-647.
63. Gorio A, Gokmen N, Erbayraktar S et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhancesneurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 2002;99:9450-9455.
64. Back SA, Han BH, Luo NL et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002;22:455-463.
65. Buser JR, Segovia KN, Dean JM et al. Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia. J Cereb Blood Flow Metab 2010;30:1053-1065.
66. Chang A, Nishiyama A, Peterson J et al. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000;20:6404-6412.
67. Jablonska B, Aguirre A, Raymond M et al. Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nat Neurosci 2010;13:541-550.
68. Etxeberria A, Mangin JM, Aguirre A et al. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat Neurosci 2010;13:287-289.
69. Suzuki SO, Goldman JE. Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: A dynamic study of glial and neuronal progenitor migration. J Neurosci 2003;23:4240-4250.
70. Fagel DM, Ganat Y, Silbereis J et al. Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp Neurol 2006;199:77-91.
71. Fagel DM, Ganat Y, Cheng E et al. Fgfr1 is required for cortical regeneration and repair after perinatal hypoxia. J Neurosci 2009;29:1202-1211.
72. Yang Z, Levison SW. Perinatal hypoxic/ischemic brain injury induces persistent production of striatal neurons from subventricular zone progenitors. Dev Neurosci 2007;29:331-340.
73. Billiards SS, Haynes RL, Folkerth RD et al. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008;18:153-163.
74. Segovia KN, McClure M, Moravec M et al. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 2008;63:520-530.
75. Ono K, Takebayashi H, Ikeda K et al. Regional- and temporal-dependent changes in the differentiation of Olig2 progenitors in the forebrain, and the impact on astrocyte development in the dorsal pallium. Dev Biol 2008;320:456-468.
76. Chen Y, Miles DK, Hoang T et al. The basic helix-loop-helix transcription factor olig2 is critical for reactive astrocyte proliferation after cortical injury. J Neurosci 2008;28:10983-10989.
77. Rowitch DH. Glial specification in the vertebrate neural tube. Nat Rev Neurosci 2004;5:409-419.
78. Mi S, Miller RH, Tang W et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009;65:304-315.
79. Mi S, Hu B, Hahm K et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007;13:1228-1233.
80. McTigue DM, Horner PJ, Stokes BT et al. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 1998;18:5354-5365.
81. Girard C, Bemelmans AP, Dufour N et al. Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci 2005;25:7924-7933.
82. Aharoni R, Herschkovitz A, Eilam R et al. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2008;105:11358-11363.
83. Skihar V, Silva C, Chojnacki A et al. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc Natl Acad Sci USA 2009;106:17992-17997.
84. Brines ML, Ghezzi P, Keenan S et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000;97:10526-10531.
85. Bernaudin M, Marti HH, Roussel S et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999;19:643-651.
86. Xiong Y, Lu D, Qu C et al. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J Neurosurg 2008;109:510-521.
87. Grasso G, Sfacteria A, Meli F et al. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res 2007;1182:99-105.
88. Vitellaro-Zuccarello L, Mazzetti S, Madaschi L et al. Erythropoietin-mediated preservation of the white matter in rat spinal cord injury. Neuroscience 2007;144:865-877.
89. Zhu C, Kang W, Xu F et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009;124:e218-e226.
90. Zhang L, Chopp M, Zhang RL et al. Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. PLoS One 2010;5:e11016.
91. Lapchak PA. Erythropoietin molecules to treat acute ischemic stroke: A translational dilemma! Expert Opin Investig Drugs 2010;19:1179-1186.
92. Velly L, Pellegrini L, Guillet B et al. Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? Pharmacol Ther 2010;128:445-459.
93. Sola A, Wen TC, Hamrick SE et al. Potential for protection and repair following injury to the developing brain: A role for erythropoietin? Pediatr Res 2005;57:110R-117R.
94. Sanchez PE, Navarro FP, Fares RP et al. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J Comp Neurol 2009;514:403-414.
95. Imai N, Higuchi M, Kawamura A et al. Physicochemical and biological characterization of asialoerythropoietin. Suppressive effects of sialic acid in the expression of biological activity of human erythropoietin in vitro. Eur J Biochem 1990;194:457-462.
96. Sanchez PE, Fares RP, Risso JJ et al. Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proc Natl Acad Sci USA 2009;106:9848-9853.
97. Niehaus A, Stegmuller J, Diers-Fenger M et al. Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration. J Neurosci 1999;19:4948-4961.
98. Zhao C, Teng EM, Summers RG, Jr. et al. Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus. J Neurosci 2006;26:3-11.